KIR/HLA Pleiotropism: Protection against Both HIV and Opportunistic Infections

• Ying Qi,

  Affiliation Laboratory of Genomic Diversity, SAIC-Frederick, Inc., National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Maureen P Martin,

  Affiliation Laboratory of Genomic Diversity, SAIC-Frederick, Inc., National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Xiaojiang Gao,

  Affiliation Laboratory of Genomic Diversity, SAIC-Frederick, Inc., National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• Lisa Jacobson,

  Affiliation Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• James J Goedert,

  Affiliation Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America

  ⨯
• Susan Buchbinder,

  Affiliation San Francisco Department of Public Health, San Francisco, California, United States of America

  ⨯
• Gregory D Kirk,

  Affiliation Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Stephen J O'Brien,

  Affiliation Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland, United States of America

  ⨯
• John Trowsdale,

  Affiliation Department of Pathology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Mary Carrington

  *To whom correspondence should be addressed. E-mail: carringt@ncifcrf.gov

  Affiliations Laboratory of Genomic Diversity, SAIC-Frederick, Inc., National Cancer Institute, Frederick, Maryland, United States of America , Laboratory of Genomic Diversity, SAIC-Frederick, Inc., National Cancer Institute, Frederick, Maryland, United States of America

  ⨯